Cadila Healthcare Limited has informed the Exchange about press release dated 09-Mar-2022 titled ���Zydus receives final approval from USFDA for Nitroglycerin Sublingual Tablets���.
Press Release Mar 09 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Mar 08 2022
- Press Release Mar 07 2022
- Press Release Feb 23 2022
- Press Release Feb 14 2022
- Press Release Feb 02 2022
Later from Zydus Lifesciences
- Press Release Mar 14 2022
- Press Release Mar 21 2022
- Press Release Apr 01 2022
- Press Release Apr 13 2022
- Press Release Apr 18 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences